Jpmorgan Chase & CO Pulmonx Corp Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Pulmonx Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 654,383 shares of LUNG stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
654,383
Previous 768,430 14.84%
Holding current value
$2.05 Million
Previous $5.22 Million 15.6%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$5.68 - $9.22 $647,786 - $1.05 Million
-114,047 Reduced 14.84%
654,383 $4.4 Million
Q4 2024

Feb 12, 2025
SELL
$5.93 - $7.71 $1.7 Million - $2.21 Million
-287,092 Reduced 27.2%
768,430 $5.22 Million
Q3 2024

Dec 26, 2024
BUY
$5.59 - $8.58 $139,761 - $214,517
25,002 Added 2.43%
1,055,522 $8.75 Million
Q3 2024

Nov 08, 2024
BUY
$5.59 - $8.58 $139,761 - $214,517
25,002 Added 2.43%
1,055,522 $8.75 Million
Q2 2024

Dec 26, 2024
SELL
$5.77 - $9.82 $144,261 - $245,519
-25,002 Reduced 2.37%
1,030,520 $6.53 Million
Q2 2024

Aug 12, 2024
BUY
$5.77 - $9.82 $4.42 Million - $7.52 Million
765,945 Added 289.5%
1,030,520 $6.53 Million
Q1 2024

Dec 26, 2024
SELL
$8.71 - $14.65 $6.89 Million - $11.6 Million
-790,947 Reduced 74.93%
264,575 $2.45 Million
Q1 2024

May 10, 2024
BUY
$8.71 - $14.65 $1.85 Million - $3.11 Million
212,312 Added 406.24%
264,575 $2.45 Million
Q4 2023

Dec 26, 2024
SELL
$7.89 - $13.14 $7.92 Million - $13.2 Million
-1,003,259 Reduced 95.05%
52,263 $666,000
Q4 2023

Feb 12, 2024
BUY
$7.89 - $13.14 $211,696 - $352,559
26,831 Added 105.5%
52,263 $666,000
Q3 2023

Nov 14, 2023
SELL
$9.88 - $14.0 $39,401 - $55,832
-3,988 Reduced 13.56%
25,432 $262,000
Q2 2023

Aug 11, 2023
SELL
$10.78 - $13.65 $1.28 Million - $1.62 Million
-118,798 Reduced 80.15%
29,420 $385,000
Q1 2023

May 18, 2023
BUY
$7.49 - $12.54 $333,462 - $558,293
44,521 Added 42.93%
148,218 $1.66 Million
Q1 2023

May 11, 2023
BUY
$7.49 - $12.54 $343,663 - $575,372
45,883 Added 79.36%
103,697 $1.16 Million
Q4 2022

Feb 13, 2023
BUY
$4.92 - $17.35 $123,250 - $434,634
25,051 Added 76.46%
57,814 $487,000
Q3 2022

Nov 14, 2022
BUY
$15.35 - $23.99 $15,749 - $24,613
1,026 Added 3.23%
32,763 $545,000
Q2 2022

Aug 11, 2022
BUY
$14.0 - $27.95 $68,978 - $137,709
4,927 Added 18.38%
31,737 $467,000
Q1 2022

May 11, 2022
SELL
$21.13 - $35.65 $523,897 - $883,906
-24,794 Reduced 48.05%
26,810 $665,000
Q4 2021

Feb 10, 2022
SELL
$29.72 - $45.1 $3.2 Million - $4.85 Million
-107,589 Reduced 67.58%
51,604 $1.66 Million
Q3 2021

Nov 12, 2021
BUY
$35.98 - $44.48 $5.73 Million - $7.08 Million
159,193 New
159,193 $5.73 Million

Others Institutions Holding LUNG

# of Institutions
127
Shares Held
32.5M
Call Options Held
2.6K
Put Options Held
216K
View Full List

About Pulmonx Corp

LUNG Quotes by TradingView
  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $117M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email